Researchers track Real-World results of prostate cancer drug combo
NCT ID NCT06661122
Summary
This study is collecting and reviewing the medical records of 100 Japanese men with a specific type of prostate cancer that has spread to a few bones. The men are already receiving a three-drug treatment (darolutamide, hormone therapy, and chemotherapy) as part of their normal care. The goal is to learn more about how safe and effective this drug combination is in everyday medical practice, without changing anyone's treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
RECRUITINGMultiple Locations, Japan
Conditions
Explore the condition pages connected to this study.